Oregon Oncology Specialists Salem

Salem, Oregon 97301

2 studies enrolling now · 2 studies all time

What they study most

Chronic Myelogenous Leukemia - Chronic Phase, Early Breast Cancer

Studies at this site

• A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy — Recruiting now
• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now